Envestnet Asset Management Inc. Acquires 50,163 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Envestnet Asset Management Inc. lifted its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 20.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 299,791 shares of the company's stock after purchasing an additional 50,163 shares during the quarter. Envestnet Asset Management Inc. owned 1.99% of U.S. Physical Therapy worth $26,594,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of USPH. HighTower Advisors LLC lifted its position in U.S. Physical Therapy by 13.6% during the third quarter. HighTower Advisors LLC now owns 4,714 shares of the company's stock valued at $399,000 after purchasing an additional 566 shares during the period. Stifel Financial Corp boosted its position in U.S. Physical Therapy by 12.1% in the third quarter. Stifel Financial Corp now owns 57,166 shares of the company's stock worth $4,838,000 after purchasing an additional 6,154 shares during the last quarter. State Street Corp increased its position in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock valued at $56,522,000 after purchasing an additional 99,244 shares during the last quarter. MML Investors Services LLC increased its position in shares of U.S. Physical Therapy by 12.7% during the 3rd quarter. MML Investors Services LLC now owns 11,826 shares of the company's stock valued at $1,001,000 after purchasing an additional 1,329 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of U.S. Physical Therapy in the 3rd quarter worth approximately $573,000.

Remove Ads

U.S. Physical Therapy Price Performance

Shares of NYSE:USPH traded down $0.30 during trading on Tuesday, hitting $69.55. 158,100 shares of the company's stock were exchanged, compared to its average volume of 105,925. The business's 50-day simple moving average is $77.60 and its 200 day simple moving average is $85.11. The company has a market cap of $1.06 billion, a price-to-earnings ratio of 73.99, a PEG ratio of 3.54 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $108.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. As a group, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 14th were given a dividend of $0.45 per share. The ex-dividend date was Friday, March 14th. This represents a $1.80 annualized dividend and a dividend yield of 2.59%. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's payout ratio is currently 97.83%.

Insider Activity

In related news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This represents a 19.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on USPH shares. Citizens Jmp upgraded shares of U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. JMP Securities began coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an "outperform" rating and a $113.00 price objective for the company. JPMorgan Chase & Co. cut their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Finally, Barrington Research decreased their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.